Showing results (381-390 of 412) with videos related to

Sort By:
Pageof 42
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2026
Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 studyR J Motzer, L Albiges, S A Treviño Aguirre, et al.
The Lancet. Oncology|June 10, 2016
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialToni K Choueiri, Bernard Escudier, Thomas Powles, et al.
European Journal of Heart Failure|July 14, 2011
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart FailureStephan Waldmüller, Jeanette Erdmann, Priska Binner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion studyMatthew R Smith, Christopher J Sweeney, Paul G Corn, et al.
Immunity|December 9, 2020
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19Petra Bacher, Elisa Rosati, Daniela Esser, et al.
Nature Immunology|February 20, 2019
c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host-microbiota homeostasisChristian Neumann, Jonas Blume, Urmi Roy, et al.
The New England Journal of Medicine|September 26, 2015
Cabozantinib versus Everolimus in Advanced Renal-Cell CarcinomaToni K Choueiri, Bernard Escudier, Thomas Powles, et al.
Pageof 42